These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 31706282)
1. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy. Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282 [TBL] [Abstract][Full Text] [Related]
2. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society. Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062 [TBL] [Abstract][Full Text] [Related]
3. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors. Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057 [TBL] [Abstract][Full Text] [Related]
4. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature. Wysozan TR; Khelifa S; Turchan K; Alomari AK J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729 [TBL] [Abstract][Full Text] [Related]
5. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z; Buljan M; Busam KJ J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [TBL] [Abstract][Full Text] [Related]
7. BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome. Zaayman M; Nguyen P; Silfvast-Kaiser A; Frieder J; West C; Tumminello K; Paek SY J Dermatolog Treat; 2022 Jun; 33(4):1855-1860. PubMed ID: 34106034 [TBL] [Abstract][Full Text] [Related]
8. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers. Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087 [TBL] [Abstract][Full Text] [Related]
9. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome. Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346 [TBL] [Abstract][Full Text] [Related]
10. BAP1 Tumour Predisposition Syndrome: A New Mutation in One Family. Satolli F; de Felici del Giudice MB; Bertolani M; Ricci R; Lotti T; Zucchi A; Feliciani C Acta Derm Venereol; 2019 Oct; 99(11):1045-1046. PubMed ID: 31314123 [No Abstract] [Full Text] [Related]
11. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779 [TBL] [Abstract][Full Text] [Related]
12. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737 [TBL] [Abstract][Full Text] [Related]
14. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature. Donati M; Šteiner P; Kazakov DV Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076 [TBL] [Abstract][Full Text] [Related]
15. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing. Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904 [TBL] [Abstract][Full Text] [Related]
16. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183 [TBL] [Abstract][Full Text] [Related]